1. Introduction {#sec0001}
===============

Major depressive disorder (MDD) is a common psychiatric disorder characterized by deficits in regulating one\'s own emotions ([@bib0001]; [@bib0003]). In MDD patients, one of the most notable changes revealed by functional magnetic resonance imaging (fMRI) is abnormalities in brain functional connectivity (FC) ([@bib0019]; [@bib0024]; [@bib0043]; [@bib0059]), which have been suggested as a potential mechanism underlying their emotional and cognitive symptoms ([@bib0031]; [@bib0047]).

Traditional fMRI studies were performed under the assumption that pattern of brain FC remains stationary during the whole scanning period. Recently, however, it has been shown that brain FC fluctuates over time at sub-minute scales, which cannot be assessed by conventional static FC analysis methods ([@bib0012]; [@bib0022]). Therefore, "dynamic FC" has become a new topic in neuroimaging studies to track fluctuations in brain FC patterns ([@bib0034]). Notably, such fluctuations have been demonstrated to be involved in a wide range of cognitive and affective processes such as attention ([@bib0036]), learning ([@bib0004]), executive functions ([@bib0007]), internally-oriented cognition ([@bib0055]) and mood ([@bib0006]), as well as a number of common psychiatric disorders such as autism ([@bib0058]), bipolar disorder ([@bib0032]) and schizophrenia ([@bib0015]; [@bib0020]). These findings highlight the importance of dynamic FC in understanding brain functions in both healthy and psychiatric populations.

Despite accumulating knowledge on dynamic features of brain FC, their relationships with MDD still remain unclear. Although a few studies ([@bib0014]; [@bib0021]; [@bib0025]; [@bib0046]; [@bib0049]; [@bib0054]; [@bib0062]) have started to investigate dynamic FC in MDD, these studies had several limitations. Firstly, the results reported from these studies are inconsistent. For example, while an earlier study ([@bib0014]) found that MDD was related to decreased temporal variability of FC within the default-mode network (DMN), the opposite results were reported by two other studies ([@bib0025]; [@bib0049]). Such inconsistency may be partly due to relatively small sample sizes in these previous studies (see Supplemental Table S1 for a review), which could result in a relatively low reliability in neuroimaging studies ([@bib0009]; [@bib0011]). Secondly, most previous studies were only focused on either fluctuations of FC within predefined regions of interests (ROIs) such as the medial prefrontal cortex (mPFC) ([@bib0025]; [@bib0049]), or changes in whole-brain connectivity states ([@bib0054]). However, characterizations of dynamic FC in MDD from both local and global perspectives remain poorly examined. Therefore, it is necessary to investigate global and local dynamics of FC in MDD with a larger well-powered sample to improve our understanding of this common mental disorder.

In this study, we aimed to characterize alterations of dynamic FC in MDD using a large, multi-site sample drawn from the REST-meta-MDD Project in China ([@bib0052]). To reach this goal, we used a novel dynamic network-based approach that allows us to identify altered dynamic FC patterns at both regional and global levels ([@bib0038]). Specially, the brain is modeled as a multi-layer dynamic network, in which the layers represent brain FC patterns at different time points. Based on this model, metrics of several key spatio-temporal features of dynamic networks, including the temporal variability, temporal clustering and temporal efficiency, were estimated and compared between the MDD patients and healthy subjects. According to previous findings of the existence of altered dynamic FC in MDD ([@bib0025]; [@bib0049]), we hypothesize that MDD would disrupt the spatio-temporal organization of dynamic brain networks, leading to alterations in these metrics (e.g., increased temporal variability) in patients.

2. Methods and materials {#sec0002}
========================

2.1. Subjects {#sec0003}
-------------

The analyzed sample consisted of 460 MDD patients and 473 healthy controls (HCs) recruited from 9 study sites across China, as a part of the REST-meta-MDD consortium ([@bib0052]). All subjects included were 18--65 years of age, with at least 5 years of education, and with an fMRI scan repetition time of 2 s and scan time ≥ 8 min. All patients met the Diagnostic and Statistical Manual of Mental Disorders-IV criteria for MDD ([@bib64]), and had a total score ≥ 8 on the 17-item Hamilton Depression Rating Scale (HAMD) ([@bib0048]) at the time of scanning. Episodicity and medication information were available for a total of 372 patients from 6 sites, among which 155 were in their first episode of illness and had never taken antidepressants. Data on duration of illness were available for 382 patients from 7 sites. All study sites obtained approval from their local institutional review boards and ethics committees, and all participants provided written consent at their local institutions. See [Tables 1](#tbl0001){ref-type="table"} and [2](#tbl0002){ref-type="table"} for sample details, and more details about the inclusion and exclusion criteria can be found in Supplemental Materials.Table 1The contributing sample size, clinical information of patients, and key data acquisition parameters of each site included in the current study. The nine sites were respectively located in: 1) the First Affiliated Hospital of Chongqing Medical University, Chongqing; 2) Affiliated Zhongda Hospital of the Southeast University, Nanjing; 3) the First Affiliated Hospital of Chongqing Medical University, Chongqing; 4) Anhui Medical University, Hefei; 5) Southwest University, Chongqing; 6) Beijing Anding Hospital of the Capital Medical University, Beijing; 7) the Second Xiangya Hospital of the Central South University, Changsha; 8) the West China Hospital of Sichuan University, Chengdu; 9) Affiliated Zhongda Hospital of the Southeast University, Nanjing.Table 1SiteSamplesClinical information of patientsMR ScannerTR (ms)TE (ms)Time pointsMDD patientsHCsHAMD score (mean ± SD)Duration of illness/month (mean ± SD)[a](#tb1fn1){ref-type="table-fn"}FEDN/non-FEDN/unknown)119524.632 ± 5.31530.737 ± 56.85413/6/0GE 3T2000302402353831.057 ± 5.40136.571 ± 55.14335/0/0Siemens 3T2000252403414120.659 ± 5.695unavailable0/0/41GE 3T2000402404213421.619 ± 7.11099.095 ± 103.3420/21/0GE 3T200022.5240522122621.448 ± 5.05749.986 ± 64.93296/117/8Siemens 3T2000302426606417.683 ± 6.48590.344 ± 100.5251/59/0Siemens 3T2000302407212023.762 ± 5.57627.658 ± 25.8330/0/21Philips 3T2000302508242921.583 ± 5.35625.208 ± 29.12310/14/0Philips 3T2000302409181610.111 ± 2.541unavailable0/0/18Siemens 3T200025240[^1]Table 2The demographic, clinical and image (head motion) characteristics of each group.Table 2Major depressive disorder (*n* = 460)Health controls (*n* = 473)Group comparisons(Mean ± SD)(Mean ± SD)Age, years36.785 ± 13.21536.911 ± 15.252*t* = −0.135, *p* = 0.892Sex, male/female155/305177/296*χ*^2^ = 1.412, *p* = 0.235Education level, years11.427 ± 3.23512.980 ± 3.479*t* = −7.061, *p* \< 0.001Mean FD0.068 ± 0.0330.070 ± 0.035*t* = −0.866, *p* = 0.38717-item HAMD scores21.525 ± 6.642//Duration of illness, months[a](#tb2fn1){ref-type="table-fn"}54.311 ± 73.120//[^2]

2.2. Data acquisition, preprocessing and quality control {#sec0004}
--------------------------------------------------------

Resting-state fMRI and structural T1-weighted MRI brain scans were acquired at each site (see [Table 1](#tbl0001){ref-type="table"} for key data acquisition parameters) and were preprocessed using the DPARSF software ([@bib0051]) with a standardized protocol ([@bib0052], [@bib0053]). To control for head motion and physiological noises, the Friston-24 head motion parameters, liner trends, as well as signals from the white matter, cerebrospinal fluid and whole brain were regressed out from the images ([@bib0018]; [@bib0028]; [@bib0030]). Subjects with poor image quality or excessive head motion (mean framewise-displacement (FD) ([@bib0023]) \> 0.2 mm) were excluded from analysis. See Supplemental Materials for further details.

2.3. Construction of dynamic brain network {#sec0005}
------------------------------------------

As summarized in [Fig. 1](#fig0001){ref-type="fig"}, multi-layer dynamic brain networks were constructed using a widely-used sliding-window approach ([@bib0028]; [@bib0035]; [@bib0041]) with nodes defined by the 160 ROIs in the Dosenbach functional atlas, which were derived from previous meta-analyses ([@bib0016]) (see Supplemental Table S2 for list of ROIs). The mean time series of each of the 160 nodes were firstly extracted and divided into a number of continuous time windows ([Fig. 1](#fig0001){ref-type="fig"}**A**). According to the previous recommendations ([@bib0029]; [@bib0041]; [@bib0056]), a window length of 100 s and a step length of 6 s were used in the primary analyses. This produced a total of 61 windows, and the whole-brain connectivity matrices were then calculated within each window using pairwise Pearson correlations. As a result, a multi-layer dynamic network *G* = (*G~t~*)~*t* =1,2,3,...,61~, where *G~t~* is the layer representing brain FC within the *t*th time window, was obtained for each subject ([Fig. 1](#fig0001){ref-type="fig"}**B**). See Supplemental Materials for more details.Fig. 1The procedures for constructing dynamic brain networks and computing dynamic network metrics. (**A**) The time series for all nodes were divided into a number of continuous time windows. (**B**) The whole-brain connectivity matrices were calculated within each window to compose a dynamic network, whose temporal variability was then estimated by average dissimilarities between different windows. (**C**) The dynamic brain networks were further thresholded and binarized with a range of sparsities from 10% to 50%, at which temporal clustering and temporal efficiency were estimated. TR = repetition time.Fig 1

2.4. Dynamic brain network metrics {#sec0006}
----------------------------------

After constructing dynamic networks, we estimated several key spatio-temporal features of dynamic brain networks, including the temporal variability, temporal clustering and temporal efficiency, described as following:

*Temporal variability*: The variability of a dynamic brain network over time was measured by the average dissimilarity of its network structures between different time windows ([@bib0015]; [@bib0021]; [@bib0058]). This was computed at both the global (*temporal variability*) and regional (*nodal temporal variability*) levels. Both of the measures range from 0 to 2, and a higher value indicates a higher variability.

*Temporal clustering:* Temporal clustering measures the consistency of each node\'s connected neighbors between consecutive time points, named the *temporal correlation coefficient* and *nodal temporal correlation coefficient* at global and regional levels, respectively ([@bib0038]; [@bib0042]). They both range from 0 to 1, and a higher value indicates a higher consistency (higher temporal clustering).

*Temporal efficiency:* Temporal efficiency quantifies how quickly information can transmit between nodes in a dynamic network, named the *characteristic temporal path length* for the whole-brain and *nodal temporal path length* for each node ([@bib0038]). These two measures range from 1 to infinite, with a lower value representing a shorter average temporal distance between nodes and a shorter time for information to be transferred between nodes on average (higher temporal efficiency) ([@bib0038]; [@bib0044]).

Since temporal clustering and temporal efficiency are only defined for binary networks ([@bib0038]), we obtained binary dynamic networks by preserving only a particular proportion ("sparsity") of the strongest connections between nodes on the FC matrices of each window ([Fig. 1](#fig0001){ref-type="fig"}**C**). The metrics of temporal clustering and temporal efficiency were computed across a wide range of sparsities from 10% to 50% with an increment interval of 1%, to ensure that results were biased by a single sparsity level ([@bib0039]; [@bib0060]; [@bib0061]). More details about these metrics and methods can be found in Supplemental Materials and Supplemental Fig. S1-S2, as well as a previous publication ([@bib0038]).

2.5. Statistics {#sec0007}
---------------

Temporal variability of the dynamic brain network was compared between the MDD and HCs groups by analysis of covariance (ANCOVA), where group was included as dependent variable, covarying for age, sex, education, mean FD and site. Similarly, the temporal correlation coefficient and characteristic temporal path length were compared using repeated-measures ANCOVA models, in which sparsity level (10% to 50%) was included as within-subject factor and group as a between-subject factor, with the same above covariates. We further investigated their associations with HAMD scores and duration of illness (when available) in patients using partial Spearman rank correlations, adjusting for age, sex and site. The temporal correlation coefficient and characteristic temporal path length were averaged across all sparsities before the correlation analyses. Significance was set at *p* \< 0.05 after Benjamini-Hochberg false discovery rate (FDR) corrections across the three measures.

When significant between-group differences were detected on any of the examined dynamic network metrics, we further investigated which regional changes might particularly drive those effects. For that we compared the corresponding nodal metrics between groups for each of the 160 ROIs, using the same above ANCOVA or repeated-measures ANCOVA models. Similarly, their associations with the HAMD scores and duration of illness were examined using the partial Spearman rank correlations adjusting for age, sex and site. Significance was set at *p* \< 0.05 after FDR corrections across the 160 ROIs. Results were visualized using the BrainNet Viewer ([@bib0050]).

2.6. Subgroup analyses {#sec0008}
----------------------

Subgroup analyses were performed to explore the possible influences of illness episodes and medication. Here, the MDD patients were divided into subgroups of first-episode, drug-naïve (FEDN) (*N* = 155) and non-FEDN (*N* = 217) patients, whose demographic and clinical information can be found in Supplemental Table S3. The metrics showing significant between-group differences were further compared between each pair of subgroups (FEDN vs non-FEDN, FEDN vs HCs, and non-FEDN vs HCs) using the same above ANCOVA or repeated-measures ANCOVA models; partial correlations were performed in each subgroup of patients separately, too. All analyses were FDR-corrected for number of tests (e.g., 3 metrics multiplied by 3 subgroup comparisons).

2.7. Validation analyses {#sec0009}
------------------------

To validate our findings, we additionally performed several auxiliary analyses as follows (see details in Supplemental Materials):

*Impact of parcellation schemes:* The entire analysis was rerun with a different parcellation scheme based on the automated anatomical labeling (AAL) atlas ([@bib0045]) with 90 ROIs.

*Sliding-window lengths:* A set of different window and step lengths (window/step = \[40, 60, 80, 100\]/\[4, 6, 8\] seconds) were utilized in constructing dynamic networks to estimate the reproducibility of results across different analysis parameters.

*Subset analyses:* To evaluate whether the results were affected by sample population or unmatched education levels, group differences on each metric were tested within each of the following subsets: 1) the subsets of each individual site; 2) two split-half subsets randomly split from the whole sample; and 3) a subset extracted from the whole sample where education levels were matched between groups, by excluding all healthy subjects with years of education ≥ 16 or age ≥ 60. See Supplemental Table S4 for demographic and clinical information of each subset.

2.8. Data and code availability statement {#sec0010}
-----------------------------------------

Data of the REST-meta-MDD project are available at: <http://rfmri.org/REST-meta-MDD>. The dynamic network metrics were computed by a publicly-available MATLAB toolbox (<https://github.com/asizemore/Dynamic-Graph-Metrics>).

3. Results {#sec0011}
==========

3.1. Group comparisons and correlations {#sec0012}
---------------------------------------

As shown in [Fig. 2](#fig0002){ref-type="fig"}**A**-**C**, the MDD group showed a significantly higher temporal variability (*F* = 10.218, FDR-corrected *p* = 2.16×10^−3^), a significantly lower temporal correlation coefficient (*F* = 15.071, FDR-corrected *p* = 3.33×10^−4^), and a significantly shorter characteristic temporal path length (*F* = 8.768, FDR-corrected *p* = 3.14×10^−3^) compared with HCs. The differences in temporal correlation coefficient and characteristic temporal path length were significant at all sparsity levels (*p* \< 0.05, Supplemental Table S5). Moreover, the temporal variability and characteristic temporal path length were found to be significantly correlated with the HAMD scores in patients (Spearman\'s rho = 0.111 and −0.101, FDR-corrected *p* = 0.045 and 0.045 for temporal variability and characteristic temporal path length, respectively, [Fig. 2](#fig0002){ref-type="fig"}**D**), while no significant correlations were found between any metrics and duration of illness (FDR-corrected *p* \> 0.05).Fig. 2(A) Group comparison on temporal variability. (B-C) Group comparisons on the temporal correlation coefficient and characteristic temporal path length, with values at each sparsity level and average values across all sparsities (10% to 50%) both presented. (**D**) Partial correlations between each metric and the HAMD score, adjusted for age, sex and site effects. The error bars and shadows in (**A**)--(**C**) represent 95% confidence intervals, and all reported *p* values were corrected for multiple tests using the FDR method.Fig 2

At regional level, significantly increased nodal temporal variability, decreased nodal temporal correlation coefficient and decreased nodal temporal path length were found in a total of 14, 9, and 22 ROIs, respectively (FDR-corrected *p* \< 0.05). These ROIs highly overlapped among the three metrics and were chiefly located in the DMN (mPFC, precuneus, anterior/posterior cingulate gyrus, angular gyrus, and inferior temporal cortex), the sensori-motor cortex (frontal and parietal areas), and the subcortex (thalamus and basal ganglia) ([Fig. 3](#fig0003){ref-type="fig"} and Supplemental Table S6). No correlations at the ROI level survived FDR correction (corrected *p* \> 0.05).Fig. 3The nodes showing (**A**) a higher nodal temporal variability, (**B**) a lower nodal temporal correlation coefficient, and (**C**) a shorter nodal temporal path length in MDD patients than HCs (with FDR-corrected *p* \< 0.05). Sizes of plots are weighted by *F* values. ACC = anterior cingulate cortex; dFC = dorsal frontal cortex; IPS = intraparietal sulcus; *L* = left hemisphere; *R* = right hemisphere; vmPFC = ventromedial prefrontal cortex.Fig 3

3.2. Subgroup analyses {#sec0013}
----------------------

As shown in [Fig. 4](#fig0004){ref-type="fig"}, both the subgroups of FEDN and non-FEDN patients showed significantly higher temporal variability, lower temporal correlation coefficient and shorter characteristic temporal path length compared with HCs (FDR-corrected *p* \< 0.05), while no significant differences were found for any metrics between the FEDN and non-FEDN patients (FDR-corrected *p* \> 0.05). Although no correlations in any subgroup survived FDR correction (corrected *p* \> 0.05), trend-level effects with the same directionalities as observed in the overall patient sample were still present in both the FEDN and non-FEDN patients, suggesting that these correlations are not driven by illness duration or medication (Supplemental Fig. S3). However, the effect sizes in subgroups were relatively small and thus larger samples may be required in order to detect such effects.Fig. 4Results of subgroup comparisons among the first-episode, drug-naïve (FEDN) patients, non-FEDN patients and healthy controls (HCs). The error bars represent 95% confidence intervals, and all reported *p* values were corrected for multiple tests using the FDR method.Fig 4

3.3. Validation analyses {#sec0014}
------------------------

Using the AAL atlas, similar results were obtained at both global and regional levels (Supplemental Fig. S4). Similar results were also consistently found when repeating the analyses using different window/step lengths in constructing dynamic networks (Supplemental Table S7).

Significantly (or trend-level) higher temporal variability, lower temporal correlation coefficient and shorter characteristic temporal path length in MDD patients than HCs were consistently observed in 7 of the 9 sites (Supplemental Fig. S5). Such results were also consistently observed in two split-half subsets, and in the education-matched subset extracted from the whole sample (Supplemental Table S8).

4. Discussion {#sec0015}
=============

In the present study, using one of the largest MDD fMRI samples to date, we investigated resting-state dynamic FC in MDD using a novel dynamic network-based approach. The results revealed that MDD was associated with altered spatio-temporal organizations of dynamic brain networks, including increased temporal variability, decreased temporal clustering and increased temporal efficiency at both global and local levels. These results highlight the potential importance of dynamic brain network reconfiguration in neural mechanisms underlying MDD.

We found that MDD patients had a significantly higher temporal variability in organizations of their resting-sate functional brain networks compared with healthy subjects ([Fig. 2](#fig0002){ref-type="fig"}**A**). This finding is in line with most previous studies ([@bib0021]; [@bib0025]; [@bib0049]) suggesting excessive fluctuations of brain FC in MDD patients during rest, yet in conflict with one study ([@bib0014]). Recent work has shown that pooling data across different sites is an effective way to boost statistical power at only minimal cost of reliability loss in large-scale neuroimaging consortiums, especially when the total sample size \> 250 ([@bib0011]). Therefore, our findings from the large multi-site sample with \> 900 subjects may provide greater power than any of the previous studies mentioned above ([@bib0021]; [@bib0025]; [@bib0049]), offering more solid evidence that the brain FC patterns in MDD patients are temporally more variable during rest than those in healthy subjects.

Besides increased temporal variability, the MDD group showed a significantly decreased temporal correlation coefficient, which indicates lower consistency of FC patterns between consecutive time points (decreased temporal clustering) ([@bib0038]). Normal brain FC patterns have been found to maintain relatively stability over periods of time, which is known as "FC states" possibly reflecting different cognitive or emotional states ([@bib0002]; [@bib0034]; [@bib0057]). The decreased temporal clustering may indicate a disruption of such features in the brain due to excessive fluctuations of FC. The MDD patients also showed increased temporal efficiency as characterized by a significantly decreased characteristic temporal path length, which suggests shortened delays for information transfer between nodes ([@bib0038]; [@bib0044]). While speculative, such alteration may be attributed to increased aberrant brain connections, which play roles as "shortcuts" beyond the common periodic transitions across relative stable FC states ([@bib0005]; [@bib0057]), and thus may be another reflection of increased fluctuations in brain network structures.

The aberrant connections beyond normal successive FC states may interfere with meaningful interconnectedness for cognitive and mental processing ([@bib0005]; [@bib0041]; [@bib0057]). Moreover, the excessive reconfigurations of FC patterns may carry extra metabolic costs ([@bib0037]). Hence, all observed alterations in dynamic brain networks may together suggest less optimal information processing and a shift of economically balanced metabolic cost in the brains of MDD patients. Notably, these alterations were found in both FEDN and non-FEDN patients, and all of them showed significant (or trend-level) correlations with HAMD scores in the overall patient sample ([Fig. 2](#fig0002){ref-type="fig"}**D**), suggesting that they are likely to be associated with the severity of depression symptoms rather than an epiphenomenon of illness duration and pharmacological effects.

In MDD patients, brain regions showing significant alterations at the nodal level were mostly distributed in the DMN, including the mPFC, anterior/posterior cingulate cortex, angular gyrus and precuneus ([Fig. 3](#fig0003){ref-type="fig"}). These results are consistent with some previous studies, which have reported that MDD is related to excessive fluctuations of FC in DMN-related regions ([@bib0025]; [@bib0049]). It has been postulated that increased temporal variability of FC within the DMN may be associated with higher frequencies of spontaneous, internally-oriented cognition such as mind-wandering and creative thinking ([@bib0013]; [@bib0027]; [@bib0040]; [@bib0055]). In line with this interpretation, excessive fluctuations of FC in the DMN regions may reflect a failure to effectively control exaggerated internally-focused thoughts. These alterations, therefore, may be related to rumination, which is one of the core features of MDD defined as repetitive and passive focus on one\'s distress ([@bib0033]), although we are uncertain if they are the cause or the consequence of depression-related rumination. Prolonged self-referential emotional processing may further interfere with normal cognitive functions in MDD patients ([@bib0026]). Our hypotheses are supported by recent findings that temporal variabilities of FC within the DMN ([@bib0049]), and between the mPFC and insula ([@bib0025]), are all positively correlated with rumination scores in MDD; and that MDD patients generally spend longer time in the FC state associated with self-focused thinking during rest, which is related to their depressive severities and cognitive performances ([@bib0063]).

MDD-related regional alterations were also found in several subcortical structures including basal-ganglia and thalamus, as well as sensorimotor cortical regions including the frontal and parietal areas ([Fig. 3](#fig0003){ref-type="fig"}). A recent study in MDD reported increased temporal variability in basal-ganglia structures such as the pallidum, and suggested that it may be associated with impaired reward processing which could lead to anhedonia, one of the core clinical symptoms of MDD ([@bib0021]). Thus, our results further support this hypothesis. The thalamus and sensorimotor cortex are also known to be critical for relaying and processing sensory information in the brain ([@bib0008]; [@bib0010]). Therefore, excessive fluctuations of FC in these regions may reflect impairments in integrating information that underlies the emotional and sensory disturbances in MDD ([@bib0008]).

Our study has several limitations. First, some clinical information (e.g., dosage and duration of antidepressant treatment, treatment response, and use of mood stabilizers/antipsychotics) was not available in the current dataset, which has limited our abilities to further examine their possible effects. Second, the education levels were not matched between groups in the current sample. Although we have performed all the comparisons covarying for years of education and verified results in an education-matched subset, the results may partly be influenced by its effects. Third, the lengths of fMRI scans in this study were relatively short, which may to certain degree constrain the stability of the acquired signals. Lastly, while we proposed several clinical interpretations for all the observed changes in MDD patients, such as possible relationships with ruminations, they remain speculative and need to be tested in further studies.

5. Conclusions {#sec0016}
==============

In summary, we found that MDD is associated with increased temporal variability, decreased temporal clustering and increased temporal efficiency in dynamic functional brain networks during rest. These alterations mainly involved the default-mode, subcortical and sensorimotor regions, and were associated with depressive severity in patients, suggesting their important roles in the neuropathology of depression. Further studies are encouraged to replicate these findings and to examine their clinical associations with dysfunction in MDD patients in multiple domains.
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[^1]: Data on the duration of illness was available for only part of the patients. Abbreviations: MDD = major depressive disorder; HC= healthy control; FEDN = first-episode and drug-naïve; MR = magnetic resonance; TR = repetition time; TE = echo time.

[^2]: Data on the duration of illness was available for 382 patients. Abbreviations: SD = standard deviation; FD = framewise-displacement; HAMD = Hamilton Depression Rating Scale.
